Cite
HARVARD Citation
Yang, J. et al. (n.d.). 163P Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma: An interim analysis of the prospective, single-arm, phase II trial. Immuno-oncology technology. p. . [Online].